Background
Noncommunicable diseases, such as cardiovascular diseases, continue to be the leading cause of morbidity and mortality around the world. Hypertension and dyslipidemia appear to be the two most important modifiable risk factors contributing to the global rise in cardiovascular disease. Several plant preparations are currently being touted as having benefits for such cardiovascular risk factors. African moringa, Moringa stenopetala, is one of these plants used in Ethiopia. Therefore, this study aimed to assess and compare the serum lipid profiles and blood pressure measurements of Moringa stenopetala herbal tea drinkers and non-drinker hypertensive patients attending chronic care follow-up at Bale zone hospitals.
Methods
A comparative cross-sectional study, involving 128 blood samples (64 each of Moringa stenopetala herbal tea drinkers and nondrinkers), was conducted on hypertensive patients who were on chronic care follow-up from July 1 to August 30, 2021. A face-to-face interview was used to collect data, and serum LDL-c, HDL-c, TG, and TC levels were measured using a clinical chemistry analyzer. Data were analyzed using SPSS version 25, Chi-square (X2) was used to compare the relationship between categorical variables, and an independent sample t-test and one-way ANOVA were used to compare the mean of the groups. Generalized linear regression was used to study the association between continuous variables and Moringa stenopetala herbal tea consumption groups. The statistical significance was declared at p < 0.05.
Results
Moringa stenopetala herbal tea drinkers have showed statistically significant lower values than non-drinkers for LDL-c (p < 0.001), TG (p = 0.001), TC (p < 0.001), TC/HDL-c ratio (p < 0.001), and LDL-c/ HDL-c ratio (p < 0.001). The mean SBP, DBP, and MAP were significantly lower among the Moringa stenopetala tea drinkers group (p < 0.001, p = 0.002, and p < 0.001 respectively).
Conclusions
Interestingly, Moringa stenopetala herbal tea consumption has a significant health benefit by lowering blood pressure, LDL-c, TG, TC, and the ratios TC/HDL-c and LDL-c/HDL-c, which have the potential risk of developing CVDs.